Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Leilei Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0060-2012; OpenAlex author ID A5013488344. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Study of serum tumor markers in the early diagnosis of pancreatic cancer. Last author DOI 10.4251/wjgo.v17.i9.106910↗
  2. Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer. Co-author DOI 10.1038/s41598-017-00288-4↗
  3. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray. First author DOI 10.18632/oncotarget.16633↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qianxi Deng · 1 shared paper, 2025 · strength 0.30
  2. Meng Zhuo · 2 shared papers, 2017 · strength 0.14
  3. Ting Han · 2 shared papers, 2017 · strength 0.14
  4. Feng Jiao · 2 shared papers, 2017 · strength 0.14
  5. Hai Xia Hu · 2 shared papers, 2017 · strength 0.14
  6. Lei Wang · 2 shared papers, 2017 · strength 0.14
  7. Liwei Wang · 2 shared papers, 2017 · strength 0.14
  8. Jiujie Cui · 1 shared paper, 2017 · strength 0.07
  9. Lixia Wu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.